Development of Taxol and Other Endophyte Produced Anti-Cancer Agents

E-ISSN： 2212-3970|3|1|14-19

ISSN： 1574-8928

Source： Recent Patents on Anti-Cancer Drug Discovery, Vol.3, Iss.1, 2008-01, pp. : 14-19

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial (Hot Topic: Recent Development of Molecular Targeted Anti-Cancer Agents)

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 13, Iss. 3, 2013-03 ,pp. : 381-381

Bentham Science Publishers

Access to resources Recommend Favorite

Development of NGR-Based Anti-Cancer Agents for Targeted Therapeutics and Imaging

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 12, Iss. 1, 2012-01 ,pp. : 76-86

Bentham Science Publishers

Access to resources Recommend Favorite

Combination of Anti-EGFR Drugs and Other Molecular Targeted Agents as Anti-Cancer Strategy

Current Cancer Therapy Reviews, Vol. 3, Iss. 2, 2007-05 ,pp. : 117-126

Bentham Science Publishers

Access to resources Recommend Favorite

The Applications of Targeting Anti-Cancer Agents in Cancer Therapeutics

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 15, Iss. 7, 2015-01 ,pp. : 869-880

Bentham Science Publishers

Access to resources Recommend Favorite

Tetraplex Binding Molecules as Anti-Cancer Agents

Recent Patents on Anti-Cancer Drug Discovery, Vol. 1, Iss. 2, 2006-06 ,pp. : 185-200

Bentham Science Publishers

Access to resources Recommend Favorite